Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +30.88%
#3 Cysic Cysic +23.33%
#4 Fabric Protocol Fabric Protocol +19.88%
#5 Nockchain Nockchain +19.24%
#6 Bedrock Bedrock +18.65%
#7 Victoria VR Victoria VR +17.20%
#8 Velvet Velvet +17.00%
#9 Fake World Assets Fake World Assets +16.33%
#10 Tutorial Tutorial +11.41%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Rank in Stocks #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Share Price
$0.00060315
Last synced: 2024-09-27
Market Cap
$1.65M
Change (1 day)
19.64%
Change (1 year)
0.00%
Country
SE
Trade Amniotics AB (publ) (AMNI)

Category

Healthcare
EPS for Amniotics AB (publ) (AMNI)
EPS as of December 2023 TTM: $-0.04
According to Amniotics AB (publ) latest financial reports and stock price the company's current EPS (TTM) is $-0.04. At the end of 2022 the company had a EPS of $-0.03 a decrease compared to its 2021 EPS that were of $-0.04.
EPS history for Amniotics AB (publ) from 2018 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.04 -96.18%
2023 0.00 -96.18%
2022 $-0.03 -21.10%
2021 $-0.04 77.18%
2020 $-0.02 237.70%
2019 $-0.01 45.24%
2018 0.00 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -47,293.46%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -75,685.83%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -37,429.97%
BE